China Medical System Holdings Limited (HKG:0867)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.30
+0.12 (1.47%)
Apr 30, 2025, 4:08 PM HKT
14.96%
Market Cap 20.06B
Revenue (ttm) 7.95B
Net Income (ttm) 1.72B
Shares Out 2.42B
EPS (ttm) 0.71
PE Ratio 11.69
Forward PE 11.58
Dividend 0.29 (3.50%)
Ex-Dividend Date Apr 28, 2025
Volume 6,160,354
Average Volume 12,826,091
Open 8.21
Previous Close 8.18
Day's Range 8.10 - 8.31
52-Week Range 6.23 - 10.28
Beta 0.91
RSI 56.80
Earnings Date May 15, 2025

About HKG:0867

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Sector Healthcare
Founded 1995
Employees 6,141
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0867
Full Company Profile

Financial Performance

In 2024, HKG:0867's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China

On Wednesday, Alpha Cognition Inc. (NASDAQ: ACOG) and China Medical System Holdings Limited announced an exclusive licensing agreement for the development, manufacturing, and commercialization of Zun...

4 months ago - Benzinga